Biomerica Short Term Debt vs Current Deferred Revenue Analysis

BMRA Stock  USD 0.28  0.02  6.67%   
Biomerica financial indicator trend analysis is way more than just evaluating Biomerica prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biomerica is a good investment. Please check the relationship between Biomerica Short Term Debt and its Current Deferred Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomerica. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.

Short Term Debt vs Current Deferred Revenue

Short Term Debt vs Current Deferred Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biomerica Short Term Debt account and Current Deferred Revenue. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Biomerica's Short Term Debt and Current Deferred Revenue is 0.88. Overlapping area represents the amount of variation of Short Term Debt that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of Biomerica, assuming nothing else is changed. The correlation between historical values of Biomerica's Short Term Debt and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Term Debt of Biomerica are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Short Term Debt i.e., Biomerica's Short Term Debt and Current Deferred Revenue go up and down completely randomly.

Correlation Coefficient

0.88
Relationship DirectionPositive 
Relationship StrengthStrong

Short Term Debt

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.
Most indicators from Biomerica's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biomerica current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomerica. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.At present, Biomerica's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 9.1 M, whereas Selling General Administrative is forecasted to decline to about 5.2 M.
 2021 2022 2023 2024 (projected)
Gross Profit3.0M446K611K580.5K
Total Revenue18.9M5.3M5.4M7.6M

Biomerica fundamental ratios Correlations

0.270.680.980.91-0.82-0.480.910.770.430.910.230.420.810.50.710.60.880.650.990.34-0.060.14-0.070.640.46
0.270.70.120.1-0.57-0.710.46-0.030.280.46-0.550.610.13-0.15-0.140.70.480.720.32-0.09-0.290.460.30.190.68
0.680.70.540.59-0.65-0.790.70.40.530.7-0.150.690.680.360.210.80.920.840.70.33-0.230.3-0.030.730.72
0.980.120.540.87-0.79-0.310.890.750.30.890.280.260.730.440.740.440.780.50.970.280.020.07-0.070.560.3
0.910.10.590.87-0.56-0.480.70.910.570.70.390.470.840.710.660.590.850.640.860.32-0.170.04-0.240.710.45
-0.82-0.57-0.65-0.79-0.560.38-0.97-0.33-0.15-0.970.26-0.25-0.510.03-0.44-0.49-0.72-0.57-0.87-0.15-0.09-0.44-0.3-0.29-0.35
-0.48-0.71-0.79-0.31-0.480.38-0.39-0.44-0.53-0.390.07-0.98-0.45-0.54-0.04-0.98-0.68-0.93-0.46-0.10.580.070.37-0.74-0.98
0.910.460.70.890.7-0.97-0.390.480.241.0-0.140.270.630.120.520.50.810.590.940.20.080.380.210.440.34
0.77-0.030.40.750.91-0.33-0.440.480.480.480.530.470.690.780.570.540.670.570.690.21-0.22-0.13-0.330.660.43
0.430.280.530.30.57-0.15-0.530.240.480.240.290.560.640.610.310.570.620.460.40.27-0.160.2-0.070.560.55
0.910.460.70.890.7-0.97-0.391.00.480.24-0.140.270.630.120.520.50.810.590.940.20.080.380.210.440.34
0.23-0.55-0.150.280.390.260.07-0.140.530.29-0.140.050.440.620.54-0.020.08-0.110.160.4-0.12-0.52-0.450.290.01
0.420.610.690.260.47-0.25-0.980.270.470.560.270.050.430.630.070.960.610.890.390.13-0.61-0.19-0.480.730.99
0.810.130.680.730.84-0.51-0.450.630.690.640.630.440.430.650.610.540.850.550.790.68-0.010.14-0.170.670.43
0.5-0.150.360.440.710.03-0.540.120.780.610.120.620.630.650.430.570.540.480.420.39-0.39-0.46-0.720.80.56
0.71-0.140.210.740.66-0.44-0.040.520.570.310.520.540.070.610.430.160.480.20.70.520.0-0.14-0.160.30.1
0.60.70.80.440.59-0.49-0.980.50.540.570.5-0.020.960.540.570.160.750.960.580.15-0.53-0.02-0.320.740.98
0.880.480.920.780.85-0.72-0.680.810.670.620.810.080.610.850.540.480.750.80.880.41-0.140.27-0.070.780.63
0.650.720.840.50.64-0.57-0.930.590.570.460.59-0.110.890.550.480.20.960.80.640.14-0.490.1-0.230.690.89
0.990.320.70.970.86-0.87-0.460.940.690.40.940.160.390.790.420.70.580.880.640.35-0.030.18-0.020.60.44
0.34-0.090.330.280.32-0.15-0.10.20.210.270.20.40.130.680.390.520.150.410.140.350.240.01-0.190.280.13
-0.06-0.29-0.230.02-0.17-0.090.580.08-0.22-0.160.08-0.12-0.61-0.01-0.390.0-0.53-0.14-0.49-0.030.240.490.54-0.35-0.57
0.140.460.30.070.04-0.440.070.38-0.130.20.38-0.52-0.190.14-0.46-0.14-0.020.270.10.180.010.490.88-0.28-0.14
-0.070.3-0.03-0.07-0.24-0.30.370.21-0.33-0.070.21-0.45-0.48-0.17-0.72-0.16-0.32-0.07-0.23-0.02-0.190.540.88-0.58-0.4
0.640.190.730.560.71-0.29-0.740.440.660.560.440.290.730.670.80.30.740.780.690.60.28-0.35-0.28-0.580.7
0.460.680.720.30.45-0.35-0.980.340.430.550.340.010.990.430.560.10.980.630.890.440.13-0.57-0.14-0.40.7
Click cells to compare fundamentals

Biomerica Account Relationship Matchups

Biomerica fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets17.3M11.8M11.4M14.5M9.3M7.4M
Other Current Liab278.6K213.3K848.6K1.2M1.5M1.6M
Total Current Liabilities1.5M1.3M2.0M1.9M2.2M1.3M
Total Stockholder Equity14.2M9.2M8.3M11.7M6.6M4.5M
Property Plant And Equipment Net2.0M1.9M1.5M1.2M943K693.1K
Net Debt(6.9M)(2.6M)(4.5M)(8.6M)(3.4M)(3.2M)
Retained Earnings(21.9M)(28.4M)(35.1M)(42.2M)(48.2M)(45.8M)
Cash8.6M4.2M5.9M9.7M4.2M2.2M
Non Current Assets Total2.5M2.6M1.9M1.7M1.5M1.4M
Non Currrent Assets Other168.2K264.2K95.6K79K203K166.8K
Cash And Short Term Investments8.6M4.2M5.9M9.7M4.2M2.2M
Net Receivables1.8M1.5M773.8K722K947K950.1K
Common Stock Shares Outstanding10.2M11.9M12.7M14.2M16.8M17.7M
Liabilities And Stockholders Equity17.3M11.8M11.4M14.5M9.3M7.4M
Non Current Liabilities Total1.6M1.3M1.0M785K459K436.1K
Inventory2.9M3.2M2.4M2.1M2.4M2.2M
Other Current Assets1.5M370.3K320.7K300K238K285.8K
Other Stockholder Equity35.2M38.8M42.4M52.7M53.5M56.2M
Total Liab3.0M2.6M3.0M2.7M2.7M1.5M
Property Plant And Equipment Gross2.0M1.9M3.5M3.2M3.2M3.4M
Total Current Assets14.8M9.2M9.4M12.8M7.7M6.0M
Accumulated Other Comprehensive Income(39.8K)(48.0K)(73.9K)(110K)(102K)(107.1K)
Accounts Payable986.7K431K736K344K288K565.5K
Intangible Assets168.7K294.8K170K165K212K273.3K
Common Stock Total Equity711.0K774.2K939.2K984.6K1.1M622.7K
Common Stock939.2K984.6K1.0M1.3M1.5M1.6M
Other Assets168.2K264.2K363.079K90.9K86.3K
Property Plant Equipment2.0M1.9M1.5M1.2M1.4M1.5M
Net Tangible Assets14.0M8.9M8.2M11.6M13.3M7.8M
Net Invested Capital14.2M9.2M8.3M11.7M6.6M8.6M
Net Working Capital13.3M7.9M7.4M10.9M5.5M7.6M
Capital Stock964.9K984.6K1.0M1.3M1.5M1.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Biomerica offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biomerica's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biomerica Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biomerica Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomerica. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomerica. If investors know Biomerica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomerica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.37)
Revenue Per Share
0.327
Quarterly Revenue Growth
0.055
Return On Assets
(0.39)
Return On Equity
(0.76)
The market value of Biomerica is measured differently than its book value, which is the value of Biomerica that is recorded on the company's balance sheet. Investors also form their own opinion of Biomerica's value that differs from its market value or its book value, called intrinsic value, which is Biomerica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomerica's market value can be influenced by many factors that don't directly affect Biomerica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomerica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomerica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomerica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.